Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesThe positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection
Rheumatology International, 06/29/09
Orge E et al. – Study demonstrates that cyclic citrullinated peptide (CCP) antibody (a highly specific biomarker for rheumatoid arthritis in the general population) is a more useful test than rheumatoid factor (RF) among patients with chronic hepatitis C virus (HCV) infection without arthritis.
Methods- Aim was to determine whether CCP Ab was useful for the diagnosis of RA in nonarthritic pts with HCV
- Blood samples obtained from:
- 39 pts with chronic HCV infection
- 87 normal sera from volunteer blood donors, and
- 108 blood samples from pts with RA, from the rheumatology clinic
- RF was measured using the Dade-Behring nephelometer
- Abs to CCP were measured with ELISA
- Sensitivity, specificity and positive predictive value of the anti-CCP test was superior to the RF test
Related Articles
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Rheumatology International, 10/30/09
Relevance Score: 68%
Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09
Relevance Score: 67%
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
Arthritis Research & Therapy, 10/20/09
Relevance Score: 67%
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
Modern Rheumatology, 10/08/09
Relevance Score: 67%
Enhanced Pain Perception in Rheumatoid Arthritis: Novel Considerations
Current Pain and Headache Reports, 11/06/09
Relevance Score: 66%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/08/09
Serum levels of proinflammatory cytokines interleukin-1[beta], interleukin-6, and tumor necrosis factor [alpha] in mixed cryoglobulinemia
Arthritis & Rheumatism, 12/08/09
Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: A novel finding and potential therapeutic target
Rheumatology, 12/08/09
Sponsor
Article Search
Sponsor